Predictors for Pancreatic Cancer Diagnosis Following New-Onset Diabetes Mellitus
- PMID: 26492440
- PMCID: PMC4816040
- DOI: 10.1038/ctg.2015.44
Predictors for Pancreatic Cancer Diagnosis Following New-Onset Diabetes Mellitus
Abstract
Objectives: New-onset diabetes mellitus (NODM) in adults is often an early manifestation of pancreatic cancer (PaCa), but the incidence of PaCa in this cohort is rather low. We evaluated whether combining other patient factors such as age, smoking history, the absence of obesity, the presence of chronic pancreatitis (CP), and gallstone disease can result in a more enriched cohort.
Methods: After a washout period of 2 years to exclude pre-existing PaCa or DM, 507,378 non-diabetic patients in the veterans' administration healthcare system were identified. Patients <40 years (n=54,465) and those with PaCa diagnosed before the diagnosis of diabetes (n=22) were excluded. A total of 452,804 veterans were followed for development of DM or PaCa.
Results: 73,811 patients (16.3%) developed NODM during the follow-up period. One hundred and eighty-three NODM patients (0.25%) were diagnosed with PaCa within 3 years. In comparison, 434 of 378,993 remaining patients (0.11%) developed PaCa in 3 years following inclusion into the study [relative risk (RR)=2.27, 95% confidence intervals (CI) 1.96, 2.63; P<0.0001]. The risk of PaCa diagnosis was higher among patients who were non-obese (RR=1.51), were ≥65 years old (RR=2.01), were heavy smokers (RR=1.55), and had a history of CP (RR=4.72) or gallstone disease (RR=2.02). Using a combination of these risk factors in NODM patients resulted in up to 0.72% three-year risk of PaCa but captured only 17% of patients with PaCa.
Conclusions: Based on our findings, the likelihood of PaCa in adults with NODM even after adjusting for other potential risk factors for PaCa including age, body mass index, smoking, gallstones, and CP is probably not high enough to recommend routine evaluation for all these patients for underlying PaCa.
Figures
Similar articles
-
New diagnosis of chronic pancreatitis: risk of missing an underlying pancreatic cancer.Am J Gastroenterol. 2014 Nov;109(11):1824-30. doi: 10.1038/ajg.2014.318. Epub 2014 Oct 7. Am J Gastroenterol. 2014. PMID: 25286967
-
Association between Cigarette Smoking and New-Onset Diabetes Mellitus in 78,212 Koreans Using Self-Reported Questionnaire and Urine Cotinine.Diabetes Metab J. 2020 Jun;44(3):426-435. doi: 10.4093/dmj.2019.0068. Epub 2019 Nov 1. Diabetes Metab J. 2020. PMID: 31701695 Free PMC article.
-
Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study.J Clin Endocrinol Metab. 2023 May 17;108(6):1338-1347. doi: 10.1210/clinem/dgac728. J Clin Endocrinol Metab. 2023. PMID: 36548964
-
New-onset diabetes after distal pancreatectomy: a systematic review.Ann Surg. 2015 May;261(5):854-61. doi: 10.1097/SLA.0000000000000819. Ann Surg. 2015. PMID: 24983994 Review.
-
Incidence and mortality of new-onset glucose disorders in peritoneal dialysis patients in China: a meta-analysis.BMC Nephrol. 2020 Apr 29;21(1):152. doi: 10.1186/s12882-020-01820-x. BMC Nephrol. 2020. PMID: 32349684 Free PMC article. Review.
Cited by
-
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort study.Endosc Ultrasound. 2024 Mar-Apr;13(2):83-88. doi: 10.1097/eus.0000000000000057. Epub 2024 Apr 10. Endosc Ultrasound. 2024. PMID: 38947744 Free PMC article.
-
New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.BMJ Open. 2020 Nov 19;10(11):e037267. doi: 10.1136/bmjopen-2020-037267. BMJ Open. 2020. PMID: 33444177 Free PMC article.
-
Diabetes and cancer: Epidemiological and biological links.World J Diabetes. 2020 Jun 15;11(6):227-238. doi: 10.4239/wjd.v11.i6.227. World J Diabetes. 2020. PMID: 32547697 Free PMC article. Review.
-
Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.Gastroenterology. 2018 Sep;155(3):730-739.e3. doi: 10.1053/j.gastro.2018.05.023. Epub 2018 Jun 11. Gastroenterology. 2018. PMID: 29775599 Free PMC article.
-
Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.Oncotarget. 2017 Apr 25;8(17):29116-29124. doi: 10.18632/oncotarget.16249. Oncotarget. 2017. PMID: 28418859 Free PMC article.
References
-
- Gullo L, Pezzilli R, Morselli-Labate AM. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994; 331: 81–84. - PubMed
-
- Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 2006; 15: 1458–1463. - PubMed
-
- Gupta S, Vittinghoff E, Bertenthal D et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 2006; 4: 1366–1372. - PubMed
-
- Rousseau MC, Parent ME, Pollak MN et al. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. IntJ Cancer 2006; 118: 2105–2109. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous